Allen2
14年前
I should have said the SEC.
U.S. SECURITIES AND EXCHANGE COMMISSION
Litigation Release No. 21513 / May 4, 2010
Securities and Exchange Commission v. Seven Palm Investments, LLC, et al., Civil Action No. 1:10-cv-02755 (N.D. Ill.) (May 4, 2010)
The Securities and Exchange Commission filed a civil action today in the United States District Court for the Northern District of Illinois against Naperville, Illinois based Seven Palm Investments, LLC and its principal Peter P. Veugeler, together with Orlando, Florida based Cardiovascular Sciences, Inc., and Lawrence H. Hooper, Jr. of Oviedo, Florida, for antifraud and registration violations.
According to the SEC's complaint, from at least October 2007 through September 2009, Veugeler reaped a total of more than $8 million from the pump and dumps of two unrelated companies, Cardiovascular Sciences and Emergent Health Corp. The SEC alleges that Veugeler, through his company Seven Palm, promised financing to both companies in exchange for nearly all their purportedly unrestricted shares. Veugeler, among other things, entered manipulative trades in both companies' stock, allowing Seven Palm to sell its stock holdings in both companies at artificially inflated prices.
The SEC's complaint further alleges that Cardiovascular Sciences and Hooper, Cardiovascular Sciences's president and CEO, disseminated false and misleading press releases and other correspondence to investors between October 2007 and February 2008. The complaint also alleges that Veugeler reviewed and discussed with Hooper a number of the false press releases and directed him to work with a third-party stock promoter to issue the press releases to the public.
According to the SEC's complaint, Veugeler engaged in manipulative practices aimed at misleading the market to increase and maintain artificially high prices so Veugeler could resell Seven Palm's Cardiovascular and Emergent holdings for substantial gains.
The SEC's complaint further alleges that Veugeler devised a Cardiovascular promotional campaign to facilitate Seven Palm's liquidation of its Cardiovascular shares and that many of the Defendants' public misrepresentations and omissions concerned Seven Palm providing funding to Cardiovascular. The complaint alleges that public statements regarding Seven Palm providing funding to Cardiovascular were misleading because at the time they were made, Seven Palm had not provided any funding to Cardiovascular.
As alleged in the SEC's complaint, the defendants violated Sections 5(a), 5(c), and 17(a) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder. The complaint seeks a judgment against all defendants providing for injunctions, and civil money penalties. The complaint also seeks disgorgement of ill-gotten gains with prejudgment interest against Seven Palm, Veugeler, and Cardiovascular Sciences, and penny stock bars against Veugeler and Hooper.
See Also: SEC Complaint
http://www.sec.gov/litigation/litreleases/2010/lr21513.htm
scion
15年前
The Securities and Exchange Commission filed a civil action today in the United States District Court for the Northern District of Illinois against Naperville, Illinois based Seven Palm Investments, LLC and its principal Peter P. Veugeler, together with Orlando, Florida based Cardiovascular Sciences, Inc., and Lawrence H. Hooper, Jr. of Oveido, Florida, for antifraud and registration violations.
Litigation Release No. 21513 / May 4, 2010
Securities and Exchange Commission v. Seven Palm Investments, LLC, et al., Civil Action No. 1:10-cv-02755 (N.D. Ill.) (May 4, 2010)
The Securities and Exchange Commission filed a civil action today in the United States District Court for the Northern District of Illinois against Naperville, Illinois based Seven Palm Investments, LLC and its principal Peter P. Veugeler, together with Orlando, Florida based Cardiovascular Sciences, Inc., and Lawrence H. Hooper, Jr. of Oveido, Florida, for antifraud and registration violations.
According to the SEC's complaint, from at least October 2007 through September 2009, Veugeler reaped a total of more than $8 million from the pump and dumps of two unrelated companies, Cardiovascular Sciences and Emergent Health Corp. The SEC alleges that Veugeler, through his company Seven Palm, promised financing to both companies in exchange for nearly all their purportedly unrestricted shares. Veugeler, among other things, entered manipulative trades in both companies' stock, allowing Seven Palm to sell its stock holdings in both companies at artificially inflated prices.
The SEC's complaint further alleges that Cardiovascular Sciences and Hooper, Cardiovascular Sciences's president and CEO, disseminated false and misleading press releases and other correspondence to investors between October 2007 and February 2008. The complaint also alleges that Veugeler reviewed and discussed with Hooper a number of the false press releases and directed him to work with a third-party stock promoter to issue the press releases to the public.
According to the SEC's complaint, Veugeler engaged in manipulative practices aimed at misleading the market to increase and maintain artificially high prices so Veugeler could resell Seven Palm's Cardiovascular and Emergent holdings for substantial gains.
The SEC's complaint further alleges that Veugeler devised a Cardiovascular promotional campaign to facilitate Seven Palm's liquidation of its Cardiovascular shares and that many of the Defendants' public misrepresentations and omissions concerned Seven Palm providing funding to Cardiovascular. The complaint alleges that public statements regarding Seven Palm providing funding to Cardiovascular were misleading because at the time they were made, Seven Palm had not provided any funding to Cardiovascular.
As alleged in the SEC's complaint, the defendants violated Sections 5(a), 5(c), and 17(a) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder. The complaint seeks a judgment against all defendants providing for injunctions, and civil money penalties. The complaint also seeks disgorgement of ill-gotten gains with prejudgment interest against Seven Palm, Veugeler, and Cardiovascular Sciences, and penny stock bars against Veugeler and Hooper.
See Also: SEC Complaint
http://www.sec.gov/litigation/complaints/2010/comp21513.pdf
http://www.sec.gov/litigation/litreleases/2010/lr21513.htm
Izp99
15年前
CVSC. I have searched and have offered much information about CVSC quite current. Me and a group of people have asked European professionals in the medical field and health. We have obtained a good impression of CVSC. Its products are well known and valued in the public and private health services in Europe, particularly Spanish. In Europe, a company that sells products to the State is a company with great future. CVSC sells products to public and private health services. Therefore, it has future. If you do not believe me, do something smart: Do you have contacts within the world of medicine and health services? Do you know a surgeon? Do you have friends in a Hospital?. You can ask those people about CVSC products, especially, on their postoperative antiadhesion material. You'll probably reach the same conclusions as me, without me saying so. Then you will prove me right.
Izp99
15年前
The product postoperative antiadhesion of CVSC used in clinics working with IMQ (Igualatorio Medical Surgical), one of the largest insurance companies in Spain. Many hospitals, both state and private, know and use this material CVSC. It is a product with great prestige. It is foreseeable that more and more is demanded. If you want to know more, do as I do: ask medical professionals, surgeons, health clinics and hospitals. So you can know what I, and you can get an idea of the future of CVSC.
Izp99
15年前
CVSC Estimated Market Cap
$1,187,489 as of Feb 3, 2010Outstanding Shares
16,964,134 as of Apr 10, 2009Authorized Shares
100,000,000 as of Jan 1, 2008Float(shares)
2,561,000 as of Jan 1, 2008
PINKSHEETS
Izp99
15年前
Finally, I think there are reasons to be calm within CVSC. The management team has most of the common shares. There is no argument to doubt CVSC. I think the opposite: many reports have been unearthed today, all positive. No negative information. You just have to wait for economic performance. CVSC no obligation to publish them, because a company is classified as "no information". But I expect those results to the spring, in March. For the moment, has already sparked CVSC. Many people believed there was no current information CVSC, has found that it had information. Information that has been unearthed. But diamonds are also buried.
Izp99
15年前
Cardiovascular Sciences Inc. (Other OTC: CVSC.PK) (PINK:CVSC) Stock Research Trends Targets and Technical Analysis - Penny stocks pink sheets stock exchange [en]
Tags: Cardiovascular Sciences Inc.,CVSC.PK,Other OTC: CVSC.PK,PINK:CVSC,CVSC,CVSC.PK Penny stocks pink sheets stock exchange,CVSC.PK stock analysis,CVSC.PK stock trends,CVSC.PK stock research,CVSC.PK technical analysis,CVSC.PK support levels,CVSC.PK resistance levels,CVSC.PK targets,CVSC.PK trend,CVSC.PK indicators,CVSC.PK fibonacci,CVSC.PK stock quote,CVSC.PK stock chart,CVSC.PK option strategies
Posted in January 31st, 2010
Today we will analyze the stock Cardiovascular Sciences Inc. (CVSC.PK) for internet stock trading in the PK stock market,
Stock Technical indicators to notice in Cardiovascular Sciences Inc. (CVSC.PK)
1- Last bearish trend was from 0.19 $ (1/27/2010) to 0.10 $ (1/28/2010) a 0.09 $ move 2- The current bullish trend started from 0.10 $ at 1/28/2010 and is currently trading at 0.12 $. 3- CVSC.PK current support level is at 0.10 which is the 0.00 % fibonacci retracement of the last 0.09 $ move.
4- CVSC.PK current resistance level is at 0.12 which is the 23.60 % fibonacci retracement of the last 0.09 $ move.
5- According to ADX Indicator, the trend is currently strong bullish, which is getting stronger.
Cardiovascular Sciences Inc. (CVSC.PK) Short term stock chart patterns for internet stock trading :
6- The Stock traded in a bullish stock channel identifed by support at 0.100 and 0.050,resistance between 0.190 and 0.100, the stock channel is currently supported from below by 0.113 and resisted from above by 0.220.
Cardiovascular Sciences Inc. (CVSC.PK) Mid term stock chart patterns for internet stock trading :
7- The Stock traded in a bullish stock channel identifed by support at 0.100 and 0.050,resistance between 0.190 and 0.100, the stock channel is currently supported from below by 0.113 and resisted from above by 0.220.
Cardiovascular Sciences Inc. (CVSC.PK) Long term stock chart patterns for internet stock trading :
8- The Stock traded in a bullish stock channel identifed by support at 0.100 and 0.050,resistance between 0.190 and 0.100, the stock channel is currently supported from below by 0.113 and resisted from above by 0.220.
Stock Trading Conclusion:
Cardiovascular Sciences Inc. (CVSC.PK) was trading in a strong bullish wave, which is becoming stronger .
Technical indicators and stock chart patterns show no favorited direction,
recommend hold or waiting for entry .
Stock Resistance Levels : 0.121, 0.134, 0.145, 0.156, 0.190, 0.214, 0.246.
Stock Support levels : 0.115, 0.112, 0.110, 0.108, 0.100
This analysis I found on this website. I do not know the country. You can verify this by selecting the English version. Outside the U.S.A. There are analysts who are interested CVSC.http://cy.thestocksprofit.com/pink/cvsc-pk-cardiovascular-sciences-inc/
Izp99
15年前
Most likely you soon CVSC report its financial results during the second half of 2009. I do not believe to be negative, but nobody knows yet how they will be. I hope to be quite acceptable. But I do not care that much. I care more CVSC connections with other institutions such as UCF and, through its CEO, the connection with BioTechMedicalSoftware. I appreciate also the high value of their 4 patents. If CVSC was in great difficulty (which I doubt), could sell any of its patents and get a big win, because big companies really interested in them. But CVSC had no need of it. It is a fact that 90% of companies that are in the UCF program, succeed(according claim Oneal)
geopic
15年前
You and lzp99 (both aliases born in late December,) are the only two posting here. Particularly you, with promises that, usually, indicates just the reverse.
Are you for real? (Can you give something not as vague?)
Personally, took my losses, yesterday, and sold at .20
GLTY if you are real...
g.p.
alvirujov
15年前
Hello, I have a very good information about this company, with good results and medicines developed and in process. You can buy now at this level or cry the next month in your house if you didn't buy it. It's the next Decode, I advise, I will buy 1,000,000 new shares for me.